Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A patient-centric approach to optimise insulin therapy in Asia.
Goh SY, Ang E, Bajpai S, Deerochanawong C, Hong EG, Hussein Z, Joshi S, Kamaruddin NA, Kho S, Kong AP, Pan CY, Perfetti R, Vichayanrat A, Vlajnic A, Chan JC. Goh SY, et al. Among authors: vlajnic a. J Diabetes Complications. 2016 Aug;30(6):973-80. doi: 10.1016/j.jdiacomp.2016.05.019. Epub 2016 May 24. J Diabetes Complications. 2016. PMID: 27288201 No abstract available.
Validation of the SoloSTAR insulin pen.
Schwartz S, Vlajnic A. Schwartz S, et al. Among authors: vlajnic a. Diabetes Technol Ther. 2008 Oct;10(5):351-7. doi: 10.1089/dia.2008.0079. Diabetes Technol Ther. 2008. PMID: 18715210 Clinical Trial.
Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy.
Hollander P, Sugimoto D, Vlajnic A, Kilo C. Hollander P, et al. Among authors: vlajnic a. J Diabetes Complications. 2015 Nov-Dec;29(8):1266-71. doi: 10.1016/j.jdiacomp.2015.05.022. Epub 2015 Jun 5. J Diabetes Complications. 2015. PMID: 26281972 Clinical Trial.
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page